Multiomics is a new approach where the data sets of different omic groups are combined during analysis. The different omic strategies employed during multiomics are genome, proteome, transcriptome, epigenome, and microbiome.

The global Multiomics market size is projected to grow from US$ 2773 million in 2024 to US$ 5545 million in 2030; it is expected to grow at a CAGR of 12.2% from 2024 to 2030.

ReportPrime's newest research report, the “Multiomics Industry Forecast” looks at past sales and reviews total world Multiomics sales in 2022, providing a comprehensive analysis by region and market sector of projected Multiomics sales for 2023 through 2029. With Multiomics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Multiomics industry.

This Insight Report provides a comprehensive analysis of the global Multiomics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Multiomics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Multiomics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Multiomics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Multiomics.

Single cell multiomics technologies typically measure multiple types of molecules from the same individual cell, allowing for more in-depth biological insight than can be gained by analyzing each molecular layer from separate cells. Single-cell multimodal omics (scMulti-omics) technologies allow for the measurement of multiple modalities from the same cell, including DNA methylation, chromatin accessibility, RNA expression, protein abundance, gene perturbation, and spatial information, unlike live-cell fluorescence imaging, which involves the destruction of cells for analysis.

This report presents a comprehensive overview, market shares, and growth opportunities of Multiomics market by product type, application, key players and key regions and countries.

• Single-cell Multiomics
• Bulk Multiomics

• Cell Biology
• Oncology
• Neurology
• Immunology
• Others

This report also splits the market by region:

• United States
• Canada
• Mexico
• Brazil

• China
• Japan
• Korea
• Southeast Asia
• India
• Australia

• Germany
• France
• UK
• Italy
• Russia

• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• BD
• Thermo Fisher Scientific, Inc.
• Illumina, Inc
• Danaher (Beckman Coulter)
• PerkinElmer, Inc
• Shimadzu Corporation
• Bruker
• QIAGEN
• Agilent Technologies, Inc.
• BGI Genomics